Hepatocellular carcinoma-targeted effect of configurations and groups of glycyrrhetinic acid by evaluation of its derivative-modified liposomes
Yuqi Sun,1,2 Chunmei Dai,1 Meilin Yin,1 Jinghua Lu,1 Haiyang Hu,2 Dawei Chen2 1School of Pharmacy, Jinzhou Medical University, Jinzhou, China; 2School of Pharmacy, Shenyang Pharmaceutical University, Shenyang, China Background: There are abundant glycyrrhetinic acid (GA) receptors on the cellular...
Guardado en:
Autores principales: | Sun Y, Dai C, Yin M, Lu J, Hu H, Chen D |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://doaj.org/article/eeced4fbb8f44cc181da058237f9ce2f |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Glycyrrhetinic acid-functionalized mesoporous silica nanoparticles as hepatocellular carcinoma-targeted drug carrier
por: Lv Y, et al.
Publicado: (2017) -
Glycyrrhizic Acid and Its Hydrolyzed Metabolite 18β-Glycyrrhetinic Acid as Specific Ligands for Targeting Nanosystems in the Treatment of Liver Cancer
por: Luciano A. Stecanella, et al.
Publicado: (2021) -
Antibody-modified liposomes for tumor-targeting delivery of timosaponin AIII
por: Lu L, et al.
Publicado: (2018) -
Pharmacokinetics, distribution and anti-tumor efficacy of liposomal mitoxantrone modified with a luteinizing hormone-releasing hormone receptor-specific peptide
por: Zhang L, et al.
Publicado: (2018) -
Effects of Surface Charge, PEGylation and Functionalization with Dipalmitoylphosphatidyldiglycerol on Liposome–Cell Interactions and Local Drug Delivery to Solid Tumors via Thermosensitive Liposomes
por: Petrini M, et al.
Publicado: (2021)